Copyright
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Apr 26, 2019; 7(8): 928-939
Published online Apr 26, 2019. doi: 10.12998/wjcc.v7.i8.928
Published online Apr 26, 2019. doi: 10.12998/wjcc.v7.i8.928
Optimal use of fielder XT guidewire enhances the success rate of chronic total occlusion percutaneous coronary intervention
Qian-Cheng Wang, Hai-Ruo Lin, Yuan Han, Zhen-Huan Chen, Hui-Xin Hao, Jian-Ping Bin, Yu-Lin Liao, Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China
Qian-Cheng Wang, Hai Dong, Kai Xu, Shao-Yi Guan, Quan-Min Jing, Department of Cardiology, General Hospital of Northern Theater Command, Shenyang 110000, Liaoning Province, China
Author contributions: All authors helped to perform the study; Jing QM, Liao YL and Wang QC contributed to study conception and design; Jing QM, Wang QC, Dong H, Xu K, Guan SY and Han Y contributed to performing the procedures and collecting the data; Bin JP, Lin HR, Chen ZH and Hao HX contributed to interpreting the data and statistical analysis; Wang QC and Liao YL contributed to manuscript writing and made critical revision on the manuscript; All authors reviewed the manuscript and completed final approval.
Supported by the National Natural Science Foundation of China , No. 81570464 and No. 81770271 ; Special Fund for the Cultivation of College Students’ Science and Technology Innovation in 2018 , No. pdjha0095 ; and Municipal Planning Projects of Scientific Technology of Guangzhou , No. 201804020083 .
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the General Hospital of Northern Theater Command.
Informed consent statement: Patients were not required to provide informed consent to participate in this study because the analyses used anonymous clinical data that were obtained after each patient had agreed to treatment based written consent.
Conflict-of-interest statement: The authors declare no conflicts of interest regarding this manuscript.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Yu-Lin Liao, PhD, Professor, Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou 510515, Guangdong Province, China. liao18@msn.com
Telephone: +86-20-62786294 Fax: +86-20-62786294
Received: January 30, 2019
Peer-review started: January 31, 2019
First decision: March 10, 2019
Revised: March 22, 2019
Accepted: April 9, 2019
Article in press: April 9, 2019
Published online: April 26, 2019
Processing time: 87 Days and 1.5 Hours
Peer-review started: January 31, 2019
First decision: March 10, 2019
Revised: March 22, 2019
Accepted: April 9, 2019
Article in press: April 9, 2019
Published online: April 26, 2019
Processing time: 87 Days and 1.5 Hours
Core Tip
Core tip: This retrospective study aimed to investigate whether the use of Fielder XT guidewire can increase the final procedural success of chronic total occlusion-percutaneous coronary intervention via the anterograde approach. We found that the use of Fielder XT guidewire was positively associated with procedural success based on multivariate logistic regression analysis. We found no significant differences between the XT group and the no-XT group with respect to clinical parameters, lesion-related characteristics, coronary artery rupture, in-hospital death or in-hospital target lesion revascularization. However, we found significant differences between the groups with respect to success rate, procedure time, stent length, contrast amount and in-hospital complications.